Cytek Biosciences, Inc. (CTKB)
4.675
+0.06
(+1.19%)
USD |
NASDAQ |
Sep 09, 13:52
Cytek Biosciences Market Cap : 607.67M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 600.52M |
| September 04, 2026 | 610.92M |
| September 03, 2026 | 610.92M |
| September 02, 2026 | 609.62M |
| September 01, 2026 | 600.52M |
| August 31, 2026 | 621.32M |
| August 28, 2026 | 608.32M |
| August 27, 2026 | 600.52M |
| August 26, 2026 | 594.02M |
| August 25, 2026 | 595.32M |
| August 24, 2026 | 577.12M |
| August 21, 2026 | 625.22M |
| August 20, 2026 | 605.72M |
| August 19, 2026 | 610.92M |
| August 18, 2026 | 607.02M |
| August 17, 2026 | 616.12M |
| August 14, 2026 | 609.62M |
| August 13, 2026 | 635.62M |
| August 12, 2026 | 621.32M |
| August 11, 2026 | 616.12M |
| August 10, 2026 | 605.72M |
| August 07, 2026 | 545.93M |
| August 06, 2026 | 540.73M |
| August 05, 2026 | 543.33M |
| August 04, 2026 | 556.33M |
| Date | Value |
|---|---|
| August 03, 2026 | 560.23M |
| July 31, 2026 | 544.98M |
| July 30, 2026 | 556.60M |
| July 29, 2026 | 565.64M |
| July 28, 2026 | 575.98M |
| July 27, 2026 | 569.52M |
| July 24, 2026 | 575.98M |
| July 23, 2026 | 588.89M |
| July 22, 2026 | 586.31M |
| July 21, 2026 | 590.18M |
| July 20, 2026 | 591.47M |
| July 17, 2026 | 596.64M |
| July 16, 2026 | 599.22M |
| July 15, 2026 | 600.51M |
| July 14, 2026 | 596.64M |
| July 13, 2026 | 582.43M |
| July 10, 2026 | 596.64M |
| July 09, 2026 | 592.76M |
| July 08, 2026 | 566.94M |
| July 07, 2026 | 588.89M |
| July 06, 2026 | 596.64M |
| July 02, 2026 | 592.76M |
| July 01, 2026 | 591.47M |
| June 30, 2026 | 572.10M |
| June 29, 2026 | 560.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agilent Technologies, Inc. | 40.92B |
| Bio-Rad Laboratories, Inc. | 10.07B |
| Bruker Corp. | 8.268B |
| Danaher Corp. | 143.95B |
| Harvard Bioscience, Inc. | 36.78M |
Market Cap Related Metrics
| PS Ratio | 2.905 |
| PEG Ratio | -0.0066 |
| Price to Book Value | 1.887 |
| Price | 4.675 |
| Earnings Yield | -13.42% |
| PEGY Ratio | -0.0066 |